GFM
PRME icon

GF Fund Management’s Prime Medicine PRME Stock Holding History

GF Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Sell
3,822
-214
-5% -$711 ﹤0.01% 513
2026
Q1 		$14K Buy
4,036
+489
+14% +$1.86K ﹤0.01% 530
2025
Q4 		$12.3K Sell
3,547
-215
-6% -$956 ﹤0.01% 560
2025
Q3 		$20.8K Buy
3,762
+404
+12% +$1.64K ﹤0.01% 484
2025
Q2 		$8.29K Hold
3,358
– – ﹤0.01% 588
2025
Q1 		$6.68K Buy
3,358
+658
+24% +$1.68K ﹤0.01% 604
2024
Q4 		$7.88K Buy
+2,700
New +$9.48K ﹤0.01% 576

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

GF Fund Management's PRME Position: Q2 2026 in Review

GF Fund Management reduced its Prime Medicine (PRME) stake by 5.3% in Q2 2026, selling an estimated $711 and leaving 3,822 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

GF Fund Management first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.8K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • GF Fund Management held 3,822 shares of Prime Medicine worth $14.1K as of Q2 2026.
  • GF Fund Management sold 214 Prime Medicine shares in Q2 2026, an estimated $711.
  • Prime Medicine made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #513 holding.
  • GF Fund Management first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Prime Medicine position peaked at $20.8K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.